Get involved in research

Below is a list of current Australian researchers recruiting for participants. Please direct any queries about specific studies to the contact of the study.

You can search for a study by state or select All States for those studies which are national.

If you have any questions regarding content on this page or want to modify your study once submitted please email research@dementia.org.au


The Australian Dementia Network (ADNeT) - Trials screening program

This program is currently seeking patients with a diagnosis of Mild Cognitive Impairment or early Alzheimer's disease who are interested in joining a therapy (drug) trial. Patients are assessed to determine their likely eligibility for trials accepting new patients in Melbourne Victoria, and referred to these trials as appropriate.

Assessment in this program includes:

    ...

    Participating states: Victoria

    Occurring dates: 31/12/2018 to 31/12/2020

    Read more

BRAIN Study

You are invited to take part in an international research study that is investigating the effect of three types of physical exercise on brain health and physical function in older people with memory concerns.

What will the study involve for me? The research study involves a 1-year commitment from you. At the start of the study you will be randomised (like the toss of a coin) into...

Participating states: New South Wales

Occurring dates: 13/02/2019 to 13/02/2021

Read more

Together but alone: caregiver grief and loss in dementia syndromes

Caregivers of people with dementia experience grief even before their loved one has died. Previous research looking at this pre-death grief is limited and primarily undertaken with families affected by Alzheimer’s disease (AD), the most common type of dementia. Research into caregiver grief in other dementia types is lacking, even though we know they differ in many important ways.

...

Participating states: All States

Occurring dates: 08/02/2019 to 01/05/2020

Read more

Placebo controlled clinical trial of sailuotong for patients with vascular dementia or Alzheimer’s disease with cerebrovascular disease

This phase III clinical trial is investigating the efficacy and safety of a standardised Chinese herbal formula, Sailuotong (SLT) for vascular dementia or mixed dementia (Alzheimer’s disease with cerebrovascular disease). SLT, a complex combination of ginseng, ginkgo and saffron extracts, has been scientifically developed and tested by a combined team from the China Academy of Chinese...

Participating states: Australian Capital Territory

Participating states: New South Wales

Participating states: Queensland

Participating states: South Australia

Participating states: Victoria

Occurring dates: 09/12/2014 to 31/12/2020

Read more

STAREE - Statins in Reducing Events in the Elderly

STAREE is a clinical research study that is investigating whether a cholesterol lowering medication known as a statin can prolong good health and maintain independence amongst older people. STAREE will also investigate whether statin treatment can reduce the need for permanent residential care in this age group.

It is thought that statins may reduce decline in physical and mental...

Participating states: New South Wales

Occurring dates: 18/12/2018 to 31/12/2022

Read more

Virtual Dementia Friendly Rural Communities (Verily)

The Virtual Dementia Friendly Rural Communities (Verily) project is about supporting people who are caring for someone living with dementia or memory loss in a rural setting, and helping rural communities to better understand and support people with dementia and their family and friends. The research trials and evaluates innovative technology and skills-building to increase the capacity of...

Participating states: New South Wales

Participating states: South Australia

Participating states: Victoria

Occurring dates: 08/01/2018 to 20/12/2019

Read more

GRADUATE: A Phase III, randomised, double-blind, placebo-controlled, efficacy and safety study of Gantenerumab in patients with early (prodromal to mild) Alzheimer's disease

The GRADUATE study is a Phase III Placebo-controlled clinical trial investigating the efficacy and safety of an investigational medication (Gantenerumab) in patients with early (prodromal to mild) Alzheimer’s disease. This investigational medication has already had some testing in humans for safety and effectiveness and is now being tested in a larger group of people to determine if the drug...

Participating states: New South Wales

Participating states: Queensland

Participating states: South Australia

Participating states: Western Australia

Participating states: Victoria

Occurring dates: 18/05/2018 to 31/12/2019

Read more

A longitudinal investigation of the neurophysiological changes related to cognitive performance and the effects of neuromodulation in Mild Cognitive Impairment (MCI).

Do you have Mild Cognitive Impairment (MCI)? We are seeking adults aged 50 to 70 years who would like to help us investigate the effects of non-invasive form of electrical brain stimulation on brain activity and cognition over time in people who meet criteria for Mild Cognitive Impairment (MCI).

MCI refers to a decline in memory that does not impact on daily functioning. This...

Participating states: Victoria

Occurring dates: 03/10/2018 to 31/12/2021

Read more

Program for family and friends of people with a diagnosis of dementia

Carers of people with dementia face many challenges. The development of effective programs that support carers is vital to the quality of life of both the carer and the person they are caring for.

This research aims to determine the whether the StrAtegies for RelaTives (START) program is more effective in improving coping, wellbeing and mood in carers of people with dementia, than...

Participating states: All States

Occurring dates: 01/10/2016 to 01/12/2019

Read more

The Lewy Body Study

Dementia with Lewy bodies (DLB) is a relatively common form of dementia in older age. People with DLB often have similar symptoms to people with Alzheimer’s disease and Parkinson’s disease. Lewy bodies are tiny deposits of alpha-synuclein (a protein) in the nerve cells of the brain. It is not known exactly what causes the abnormal build-up of these Lewy bodies in the brain. In order to find...

Participating states: Victoria

Occurring dates: 19/07/2018 to 31/12/2020

Read more